The problem
The between-visit gap
costs the outcome
Women 35+ start gaining weight and visceral fat. They turn to GLP-1s and MHT with no instructions on what to do between visits. That gap is where lean mass, bone density, and results are lost.
— WEIGHT REGAIN
The weight comes back
80-85% regain within 1-5 years. Without lifestyle changes, GLP-1s can accelerate this once discontinued.
— LEAN MASS LOSS
Bone and lean mass risk
25-40% of weight loss can come from lean mass. GLP-1 & estrogen decline compound it.
— CLINICAL RISKS
The downstream cost
The risk the prescribing clinic carries after the patient leaves the office.
THE Hybrid core
Judgment from the model. Numbers from published protocols.
Every rep & macro trace back to peer-reviewed science, not to model output.
THE SOLUTION
Not a tracker. Not a chatbot. EvolveHer reads your biomarkers, wearable data, MHT and GLP-1 protocol, and runs the training and nutrition your outcome depends on.
01 — WEIGHT LOSS MAINTENANCE
Defend the loss
80-85% of people who lose weight regain it. We run the calorie, protein, and training targets that keep the loss off after GLP-1 dose reduction or discontinuation.
02 — MUSCLE MASS
03 — BONE DENSITY
Strengthen the frame
Estrogen decline accelerates bone loss. Loaded compound movements and micronutrient targets protect against the fractures that shorten independent aging.
THE long arc
01 — reverse diet
Structured calorie restoration
Gradual increase from deficit to maintenance, calibrated to measured lean mass rather than a formula. Prevents the rebound that follows abrupt refeeding.
02 — dose reduction
03 — multi-year
Built for the decades after
End-to-End Encryption
Data Ownership
Patient pricing
Start free.
Continue as long as it works.
Direct-to-patient access via the App Store.
No long-term commitment.
Are you a clinic? See partnership options.
the between-visit execution layer
Your protocol is ready.
Are you?
EvolveHer is live for iOS. The between-visit plan that makes your MHT and GLP-1 prescription actually work.
